GNVC doing well--all in Roth IRAs on a conversion end of last year at $.83 BNVI treading water, although I think eventually it will be a higher priced stock--maybe just not as glamorous as cancer drugs.
My own thoughts are both above $20 by the time Obama takes office again for term 2.
News 
Market Data 
Discover 
